EFTA01479567

Subject: Re: Biotech Update... note bounce in Foundation Medine on withdrawal of prior secondary offering [C] From: Tazia Smith sz: > Date: Wed, 16 Apr 2014 11:45:54 -0400 To: [email protected] Cc: Nav Gupta Paul Morris < Vahe Stepanian Vinit Sahni Classification: Confidential Jeffrey - Uptick in Biotech today ahead of earnings for the big caps (biogen, gilead, celgene) next week. Your positions below with P/L. Please note that your Foundation Medicine has really bounced off it's recent lows of $—$24 (chart below); yesterday the company withdrew a prior filing for a $150mm secondary offering. We break out Ariad because it is more M&A driven at this point than sector beta. From: Taz Stepanian Biotech Update... [C] Classification: Confidential Jeffrey - • jeevacati Paul Morris, Vahe Nav Gupta Vinit Sahni/db/- Date: 04/02/2014 03:42 PM Subject: Biotech forming a base to some extent (strong market backdrop, clearly) - you're up $906k on your basket excluding the Ariad (outlier due to M&A prospects vs. group drivers) 1-mo price history charts below. EFTA01479567 SGMO lmo Price History BIIB lmo Price History GILD lmo Price History FMI lmo Price History Tazia Smith Director I Key Client Partners - US DB Securities Inc Deutsche Asset & Wealth Management 345 Park Avenue, 10154-0004 New York, NY, USA Te Fa Mobil Email EFTA01479568